EGFR and non-small cell lung carcinoma: From a clinical standpoint, these metastases tend to be smaller in size but more disseminated in comparison to BMs associated with EGFR wt NSCLC [134], and they lead to worse outcomes in comparison to extracranial EGFR mutant NSCLC metastases [139].